A
Alcista
Alcista · 25%CAH
$146.16
Precio del escenario
$253.710
+6.114 (+2.41%)Al cierre
Loading chart…
- Máximo
- 253.940
- Apertura
- 252.000
- Precio medio ponderado por volumen
- 252.35
- Volumen
- 2.03M
- Capitalización
- 24.26B
- Mínimo
- 249.400
- Importe
- 513.42M
- EV/EBITDA, TTM
- 12.88
Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and others. It also provides pharmaceuticals and medical products. Its segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States, as well as owns a urology management services organization (MSO). Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. It connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.
Análisis de IA of Cardinal Health, Inc. (CAH)
ComprarCardinal Health Inc is a good buy right now due to its strong recent performance and positive growth outlook. The current price is $237.57, and analysts have set price targets as high as $280, indicating potential upside of over 17%. Additionally, the company has shown a year-to-date change of +15.48% and a one-year change of +53.96%, reflecting robust growth. However, the main risk is its current ratio of 0.88, indicating potential liquidity concerns.
Recomendaciones de analistas (16)
-11.25% Potencial de caída
Mantener
1 Comprar
15 Mantener
0 Vender
Actual: 253.71
Mínimo
209.00
Promedio
225.18
Máximo
244.00
RBC Capital
Superar al mercado
$276
2026-08-19
RBC Capital
2026-08-19
Precio objetivo
$276
Superar al mercado
TD Cowen
Comprar
$280
2026-08-13
TD Cowen
2026-08-13
Precio objetivo
$280
Comprar
JPMorgan
Neutral
$260
2026-08-13
JPMorgan
2026-08-13
Precio objetivo
$260
Neutral
Barclays
Sobreponderar
$275
2026-08-13
Barclays
2026-08-13
Precio objetivo
$275
Sobreponderar
Morgan Stanley
Sobreponderar
$265
2026-08-12
Morgan Stanley
2026-08-12
Precio objetivo
$265
Sobreponderar
Métricas de valoración
El PER previsto actual de Cardinal Health, Inc. (CAH) es 17.70, frente a su media de 5 años de 14.28.
Escenarios de precio de Alphio AI para CAH
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.
Ballenas con CAH en cartera
Cronología de eventos
Noticias
Preguntas frecuentes sobre CAH, respondidas por Alphio AI
Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and others. It also provides pharmaceuticals and medical products. Its segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States, as well as owns a urology management services organization (MSO). Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. It connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination. It operates in the Healthcare sector (WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRI industry).
Cardinal Health Inc is a good buy right now due to its strong recent performance and positive growth outlook. The current price is $237.57, and analysts have set price targets as high as $280, indicating potential upside of over 17%. Additionally, the company has shown a year-to-date change of +15.48% and a one-year change of +53.96%, reflecting robust growth. However, the main risk is its current ratio of 0.88, indicating potential liquidity concerns.
16 analysts cover CAH: 1 rate it Buy, 15 Hold and 0 Sell. The average price target is 225.18.
Comunidad
Más ↗Aún no hay publicaciones
Regístrate o inicia sesión para participarEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.